How much is the cell transfection market worth, and how is it expected to expand?
The cell transfection market size has grown strongly in recent years. It will grow from $1.29 $ billion in 2024 to $1.42 $ billion in 2025 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to surge in CRISPR and gene editing studies, rising funding from governments and non-governmental organizations, increasing clinical trials involving transfected cells, expansion of academic research in molecular biology, growing popularity of high-throughput screening methods.
The cell transfection market size is expected to see strong growth in the next few years. It will grow to $2 $ billion in 2029 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to rising demand for gene therapy, rising prevalence of chronic diseases, expansion of biopharmaceutical manufacturing, growth in proteomics and genomics research, growing applications of RNA-based therapeutics. Major trends in the forecast period include increasing investment in biotech and pharmaceutical research and development, advancements in transfection technologies, adoption of personalized medicine, use of transfection in cancer research, development of novel transfection reagents and kits.
Get Your Free Sample of The Global Cell Transfection Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19361&type=smp
Which industry factors have accelerated the cell transfection market’s expansion?
The increase in the number of cases of infectious disease is expected to propel the growth of the cell transfection market going forward. Infectious diseases are illnesses caused by germs that spread from one person to another or through contaminated sources. Inadequate public health infrastructure, coupled with vaccine hesitancy and misinformation, has facilitated the spread and evolution of pathogens. Cell transfection is a powerful tool for infectious diseases because it allows scientists to insert genes into cells to study how infections affect them and to test new treatments. For instance, in September 2023, according to a report published by the Australian Bureau of Statistics, an Australia-based government agency, in 2021, influenza and pneumonia-associated death rate was 31.5 per 100,000, which reached 42.6 per 100,000 in 2022. Therefore, the increase in the number of cases of infectious diseases drives the cell transfection market.
What are the primary segments of the cell transfection market?
The cell transfectionmarket covered in this report is segmented –
1) By Method: Electroporation, Lipofection, Calcium Phosphate, Viral Transfection, Other Methods
2) By Application: Biomedical Research, Therapeutic Delivery, Protein Production
3) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Other End Users
Subsegments:
1) By Electroporation: Square Wave Electroporation, Pulsed Electric Field Electroporation, Multielectrode Array Electroporation
2) By Lipofection: Cationic Lipid-Based Transfection, Lipid Nanoparticle-Based Transfection, Liposomal Transfection
3) By Calcium Phosphate: Calcium Phosphate Co-precipitation, Modified Calcium Phosphate Methods
4) By Viral Transfection: Lentiviral Transduction, Adenoviral Transduction, AAV (Adeno-Associated Virus) Transduction
5) By Other Methods: Microinjection, Nanoparticle-Mediated Transfection, Sonoporation, Magnetofection
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/cell-transfection-global-market-report
Which firms are leading the cell transfection market?
Major companies operating in the cell transfection market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Lonza Group AG, Sartorius AG, Sigma-Aldrich Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Stemcell Technologies Inc., GenScript Biotech Corporation, Promega Corporation, Takara Bio Inc., Molecular Devices LLC, New England Biolabs Inc., CureVac SE, OriGene Technologies Inc., Tocris Bioscience, Vector Biolabs, Mirus Bio LLC, Addgene Inc., Altogen Biosystems, Cell Biolabs Inc., Cellecta Inc., ExCell Bio Inc., GeneCopoeia Inc.
Which market trends are set to define the future of the cell transfection market?
Major companies operating in the cell transfection market are integrating innovations into transfection systems to enable precise control over gene expression. A transfection system is a technique or technology designed to introduce foreign nucleic acids into cells to study gene function, produce proteins, or alter gene expression. For instance, in July 2024, STEMCELL Technologies, a Canada-based biotechnology company, launched the Cellpore transfection system. It is a novel tool designed to enhance cell engineering research. This system employs advanced microfluidic technology to facilitate the intracellular delivery of various macromolecules into cells, addressing limitations associated with traditional transfection methods. It can transfect up to 10 million cells per second, making it suitable for large-scale applications. The system is compatible with various cell types, including T cells and hematopoietic stem cells. It can deliver diverse cargoes such as small molecules, Ribonucleic Acid (RNA), proteins, and antibodies.
Which geographic trends are shaping the cell transfection market, and which region has the highest market share?
North America was the largest region in the cell transfection market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell transfection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Cell Transfection Market Report 2025 Offer?
The cell transfection market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Cell transfection is a process used in molecular biology to introduce nucleic acids (such as deoxyribonucleic acid (DNA), ribonucleic acid (RNA), or oligonucleotides) into eukaryotic cells. The method allows researchers to study gene function, protein expression, and various cellular processes by manipulating the genetic content of the cells. It is a crucial tool in genetic engineering, drug discovery and various fields of biomedical research.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19361
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
